Changing the paradigm of intracranial hypertension in brain tumor patients: a study based on non-invasive ICP measurements.

Jenny Christine KienzlerRolandas ZakelisSerge MarbacherSabrina BäblerLucia SchwyzerElke RemondaJavier Fandino

Published in: BMC neurology (2020)

This study demonstrated that ICP in patients with intracranial tumors and mass effect is not necessarily increased. Therefore, clinical signs of intracranial hypertension do not necessarily reflect increased ICP.

Keyphrases

blood pressure
end stage renal disease
optic nerve
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis